Persistently raised thyroid stimulating hormone in adequately treated congenital hypothyroidism on long-term follow-up

Journal of Pediatric Endocrinology and Metabolism

Volumn 21, Issue 3, 2008, Pages 251-256

  Kara, Cengiz ^a,b   Öcal, Gönül ^a   Berberoǧlu, Merih ^a   Şiklar, Zeynep ^a   Adiyaman, Pelin ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Congenital hypothyroidism; Thyroid stimulating hormone; Treatment

Indexed keywords

LEVOTHYROXINE; THYROTROPIN; THYROXINE;

ANTHROPOMETRIC PARAMETERS; ARTICLE; CHILD; CLINICAL FEATURE; COHORT ANALYSIS; CONGENITAL HYPOTHYROIDISM; CONTROLLED STUDY; ECTOPIC HORMONE PRODUCTION; ECTOPIC THYROID GLAND; EMPTY SELLA SYNDROME; FEMALE; FOLLOW UP; GENERAL CONDITION IMPROVEMENT; HORMONAL REGULATION; HORMONAL THERAPY; HUMAN; INFANT; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NEWBORN; PATHOGENESIS; PREMEDICATION; THYROID DYSGENESIS; THYROID FUNCTION TEST; THYROTROPIN BLOOD LEVEL; THYROTROPIN RELEASE; THYROXINE BLOOD LEVEL;

EID: 42449133745     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2008.21.3.251     Document Type: Article

References (15)

1. Fisher DA. Management of congenital hypothyroidism. J Clin Endocrinol Metab 1991; 72: 523-529.
2. Redmond GP, Soyka LF. Abnormal TSH secretory dynamics in congenital hypothyroidism. J Pediatr 1981; 98: 84-85.
3. Abrusewil SSA, Tyfield L, Savage DCL. Serum thyroxine and thyroid stimulating hormone concentrations after treatment of congenital hypothyroidism. Arch Dis Child 1988; 63: 1368-1371.
4. Germak JA, Foley TP Jr. Longitudinal assessment of l-thyroxine therapy for congenital hypothyroidism. J Pediatr 1990; 117: 211-219.
5. Grant DB, Fuggle PW, Smith I. Increased plasma thyroid stimulating hormone in treated congenital hypothyroidism: relation to severity of hypothyroidism, plasma thyroid hormone status, and daily dose of thyroxine. Arch Dis Child 1993; 69: 555-558.
6. Hayderdahl S, Kase BF. Significance of elevated thyrotropin during treatment of congenital hypothyroidism. Acta Paediatr 1995; 84: 634-638.
7. Fisher DA, Schoen EJ, LaFranchi S, Mandel SH, Nelson JC, Carlton EI, Goshi JH. The hypothalamic-pituitarythyroid negative feedback control axis in children with treated congenital hypothyroidism. J Clin Endocrinol Metab 2000; 85: 2722-2727.
8. Grant DB. Monitoring TSH concentrations during treatment for congenital hypothyroidism. Arch Dis Child 1991; 66: 669-670.
9. Chiovato L, Guisti L, Tonacchera M, Ciampi M, Mammoli C, Lippi F, Lapi P, Bargagna S, Dini P, Feretti G. Evaluation of 1-thyroxine therapy for congenital hypothyroidism. J Endocrinol Invest 1991; 14: 957-960.
10. Brown J, Datta V, Sutton AJ, Swift PGF. Suppression of TSH in congenital hypothyroidism is significantly related to serum levels and dosage of thyroxine. Horm Res 2003; 59: 85-90.
11. Ng SM, Wong SC, Isherwood DM, Smith CS, Didi M. Multivariate analysis on factors affecting suppression of thyroid-stimulating hormone in treated congenital hypothyroidism. Horm Res 2004; 62: 245-251.
12. Raza J, Hindmarsh PC, Brook CGD. Factors involved in the rate of fall of thyroid stimulating hormone in treated hypothyroidism. Arch Dis Child 1997; 77: 526-527.
13. Hulse JA, Grant DB, Jackson D, Clayton BE. Growth, development, and reassessment of hypothyroid infants diagnosed by screening. BMJ 1982; 284: 1435-1437.
14. Delange F. Neonatal screening for congenital hypothyroidism: results and perspectives. Horm Res 1997; 48: 51-61.
15. Hanukoglu A, Perlman K, Shamis I, Brnjac L, Rovet J, Daneman D. Relationship of etiology to treatment in congenital hypothyroidism. J Clin Endocrinol Metab 2001; 86: 186-191.